Abstract Submission

UMDF provides the research community the opportunity to share abstracts of their projects during the Mitochondrial Medicine Conference. Abstracts should highlight major aims of your research project so Conference attendees can quickly understand the purpose and final conclusion of your work.

All submissions will be peer-reviewed by the Abstract Review Committee. Approximately 16 abstracts will be selected for oral presentations during select platforms. All approved submissions will have the opportunity to share their projects during the dedicated poster sessions.





Platform Sessions this year:

  • Advances in Disease Models for Investigating Mitochondrial Diseases
  • Mitochondria and Metabolic Plasticity
  • Disorders of Mitochondrial DNA Integrity
  • Development of Improved Outcome Measures for Mitochondrial Clinical Trials
  • Clinical Trial Updates
  • Mitochondrial Dysfunction and its Impact on Mental Health
  • Therapeutic Development for Mitochondrial Disease: Lessons learned from other Rare Diseases


Cash awards will be presented to winners during the meeting for the top four abstract presentations.

Poster dimensions should fall between 3.5 feet high by 3 feet wide (portrait oriented).

REMINDER: Submitting an abstract does NOT include registration to attend the meeting.

Please direct all abstract submission inquiries to [email protected].

DEADLINE for Abstract Submission is April 5, 2024


The deadline for abstract submission is April 5, 2024